Videos like this are made possible by our supporters. Give Today
Abortion Pill Press Conference Shares Shocking New Data
Shocking new abortion pill research was released in a press conference on Capitol Hill this morning, featuring survivor testimony from a woman who suffered devastating complications from the abortion pill, powerful remarks from several members of Congress, and the release of our newest undercover footage.
Our new investigation reveals shocking insights into how chemical abortion pills are distributed by Planned Parenthood with minimal oversight, bypassing essential safeguards and exposing women to coercion, lies, and dangerous complications.
Founder and President of Live Action, Lila Rose, released the following statement: “Today, we released a video showing how chemical abortion is actually carried out by Planned Parenthood. Staff discuss the dispensing of abortion pills without confirming the gestational age of the child, increasing the risk of undetected ectopic pregnancy and severe hemorrhage. They do not check Rh status, putting women at risk of permanent Rh sensitization that can cause miscarriage, stillbirth, or serious complications in future pregnancies. They skip basic medical history, which misses conditions and medications that raise the risk of dangerous drug interactions and uncontrolled bleeding.
They provide no real follow-up care, leaving infections, retained baby tissue, and internal bleeding untreated until women end up in emergency rooms. We documented Planned Parenthood offering to ship pills to a friend’s address, showing Planned Parenthood exposing their patients to potential abuse. Women were told to expect labor-level pain without being warned about the signs of hemorrhage or sepsis. Serious risks were consistently minimized. Planned Parenthood lied and said carrying a baby to term was more dangerous than abortion. This is standard practice at the nation’s largest abortion provider, which could regain millions in taxpayer funding later this year.
Our memo to the administration and our new white paper explain how federal regulators allowed this system to grow through years of weakened rules and incomplete reporting. The agencies charged with protecting public health now have the evidence in front of them. The FDA should revoke the approval of mifepristone as an abortifacient. Until that happens, it must immediately restore in-person exams, full medical screening, and real follow-up requirements. Every day of delay means more women harmed and more children killed.”
Find all materials for this campaign at http://abortionpillskill.com.